Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLPH | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | AL513122.1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | FAM3C | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |
mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | CECR5 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
mRNA | ATP6AP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | SERBP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
mRNA | SV2A | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | RP13-672B3.2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
mRNA | CDCA8 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |